Advantage Investment Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Advantage Investment Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,500	Closed	-$25K	–	933
2014 Q4	$25K	Buy	+1,500	New	+$21.1K	0.02%	397

Advantage Investment Management's AVNR Position: Q1 2015 in Review

Advantage Investment Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 1,500 shares — an estimated $25K sold.

Advantage Investment Management first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $25K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Advantage Investment Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Advantage Investment Management sold 1,500 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $25K.
Advantage Investment Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
Advantage Investment Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $25K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Advantage Investment Management's 13F filing for Q1 2015, filed 27 Mar 2017.